Your search returned 2705 results.

Results
	541.	[PPARalpha agonist--fenofibrate inhibits LPS-induced tissue factor expression in THP-1 cells]. [electronic resource] by Dong, Chun-Xia Hu, Yu Wang, Hua-Fang Sun, Chun-Yan Wang, Ya-Dan He, Wen-Juan Zhang, Xiao-Ping Producer: 20071220 In: Zhongguo shi yan xue ye xue za zhi vol. 14 Availability: No items available. Save to lists Add to cart (remove)
	542.	[Hepatitis induced by fibrates]. [electronic resource] by Tudesq, N Bentournes, M Producer: 20070119 In: Annales de biologie clinique vol. 64 Availability: No items available. Save to lists Add to cart (remove)
	543.	New treatments for gout. [electronic resource] by Perez-Ruiz, Fernando Producer: 20070911 In: Joint bone spine vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	544.	A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials. [electronic resource] by Simes, John Voysey, Merryn O'Connell, Rachel Glasziou, Paul Best, James D Scott, Russell Pardy, Christopher Byth, Karen Sullivan, David R Ehnholm, Christian Keech, Anthony Producer: 20100520 In: PloS one vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	545.	Diabetes: Should we use fibrates in patients with diabetes and mild CKD? [electronic resource] by Lewis, David Wanner, Christoph Producer: 20120724 In: Nature reviews. Nephrology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	546.	Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits. [electronic resource] by Fournier, Natalie Tuloup-Minguez, Véronique Pourci, Marie-Luce Thérond, Patrice Jullian, Jean-Christophe Wien, Frank Leroy, Michel Dallongeville, Jean Paul, Jean-Louis Leroy, Arnaud Producer: 20131107 In: Biochimie vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	547.	The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs. [electronic resource] by Yeap, Yan Yan Trevaskis, Natalie L Porter, Christopher J H Producer: 20141029 In: Molecular pharmaceutics vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	548.	Clay as a matrix former for spray drying of drug nanosuspensions. [electronic resource] by Dong, Yuancai Ng, Wai Kiong Hu, Jun Shen, Shoucang Tan, Reginald B H Producer: 20141211 In: International journal of pharmaceutics vol. 465 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	549.	Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD? [electronic resource] by Croyal, M Kaabia, Z León, L Ramin-Mangata, S Baty, T Fall, F Billon-Crossouard, S Aguesse, A Hollstein, T Sullivan, D R Nobecourt, E Lambert, G Krempf, M Producer: 20180928 In: Diabetes & metabolism vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	550.	Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation. Lack of interaction with the lipid-lowering agent, fenofibrate. [electronic resource] by deLorgeril, M Boissonnat, P Bizollon, C A Guidollet, J Faucon, G Guichard, J P Levy-Prades-Sauron, R Renaud, S Dureau, G Producer: 19921217 In: European journal of clinical pharmacology vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	551.	Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects. [electronic resource] by Shepherd, J Caslake, M J Lorimer, A R Vallance, B D Packard, C J Producer: 19850402 In: Arteriosclerosis (Dallas, Tex.) vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	552.	[Metabolism of fenofibrate and fenofibric acid in vivo and in cultures of liver epithelial cells (author's transl)]. [electronic resource] by Dulery, B Hammami, M Chessebeuf, M Legendre, M Noly, P Padieu, P Maume, B F Producer: 19810513 In: La Nouvelle presse medicale vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	553.	Differences in the response of serum lipoproteins to fenofibrate between women and men with primary hypercholesterolaemia. [electronic resource] by Sudhop, T Lütjohann, D Ratman, C von Bergmann, J von Bergmann, K Producer: 19961226 In: European journal of clinical pharmacology vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	554.	The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients. [electronic resource] by Coban, E Ozdogan, M Yazicioglu, G Sari, R Producer: 20050718 In: International journal of clinical practice vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	555.	[Acute cholestatic hepatitis probably due to fenofibrate]. [electronic resource] by Maroy, Bernard Producer: 20100816 In: Therapie vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	556.	PPARalpha and PPARgamma are co-expressed, functional and show positive interactions in the rat urinary bladder urothelium. [electronic resource] by Egerod, Frederikke Lihme Brünner, Nils Svendsen, Jette E Oleksiewicz, Martin B Producer: 20100525 In: Journal of applied toxicology : JAT vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	557.	Letter by Singh et al regarding article, "Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the GOLDN study". [electronic resource] by Singh, Puneetpal Di Napoli, Mario Singh, Monica Producer: 20110525 In: Circulation. Cardiovascular genetics vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	558.	Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. [electronic resource] by Bonds, D E Craven, T E Buse, J Crouse, J R Cuddihy, R Elam, M Ginsberg, H N Kirchner, K Marcovina, S Mychaleckyj, J C O'Connor, P J Sperl-Hillen, J-A Producer: 20120829 In: Diabetologia vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	559.	Systemic therapies for diabetic retinopathy: the accord eye study. [electronic resource] by Frank, Robert N Producer: 20150126 In: Ophthalmology vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	560.	Fenofibrate protects against acute myocardial I/R injury in rat by suppressing mitochondrial apoptosis as decreasing cleaved caspase-9 activation. [electronic resource] by Zhao, Qing Cui, Zheng Zheng, Yan Li, Qun Xu, Changyuan Sheng, Xueqi Tao, Mei Xu, HuiXin Producer: 20180503 In: Cancer biomarkers : section A of Disease markers vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2705 results.